Skip to main content
. 2011 Sep 15;6(9):e24856. doi: 10.1371/journal.pone.0024856

Figure 2. CCR6/CCL20 expression and NSCLC disease progression.

Figure 2

Kaplan-Meier analysis of disease free survival interval (months) according to disease stage. (A). Kaplan-Meier analysis of disease free survival interval (months) according to percentage of CCR6 positive cells. (B). CCR6 staining index for lung adenocarcinoma and squamous cell carcinoma according to disease stage is shown (C).